NCT06255262 2024-02-13
Durvalumab Combined With Surufatinib as Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
China Medical University, China
Phase 1/2 Unknown
Clinical Trials
6 trialsNCT05451173 2023-10-03
Combining ICI With SBRT or HypoFrx-RT for ES NSCLC
Xuanwu Hospital, Beijing
Phase 1/2 Unknown
NCT04646837 2023-03-29
Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models
Peking Union Medical College Hospital
Phase 1/2 Unknown
NCT05327582 2022-04-14
An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT05267392 2022-03-04
IDEAR
Instituto Portugues de Oncologia, Francisco Gentil, Porto
Phase 1/2 Unknown
NCT03051906 2017-11-22
DUCRO-HN
Azienda Ospedaliero-Universitaria Careggi
Phase 1/2 Unknown